More than two dozen “grand challenges” remain in small-molecule drug discovery, spanning everything from target selection to developing a medicine that can be safely used in the clinic, according to Woody Sherman, Ph.D., founder and chief innovation officer at PsiThera. No single company can solve all these problems alone, which underscores the importance of computational […]
